| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1542e8802a0e6a7a8a7c6bd5627eb857 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D263-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-421
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-421
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D263-32 |
| filingDate |
2004-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_428512b9b8c26e9b5c3eb3a196d2c027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5f9df09fb54817515c059b05cc36d62
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9050ee69002dd7b4c8a8b0825d016cac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_460d0e62ed0278ff3ab6d67962333c08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4afac31615ee56c98315a73e1117c9a1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a861ef15b8014ccad2279a882a723f97
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7bd89739cdda496a23d16600f8f0974f |
| publicationDate |
2006-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
DE-102004039509-A1 |
| titleOfInvention |
Aryl-cycloalkyl substituted alkanoic acid derivatives, process for their preparation and their use as medicaments |
| abstract |
The invention relates to aryl-cycloalkyl-substituted alkanoic acid derivatives and their physiologically tolerated salts and physiologically functional derivatives. There are compounds of the formula (I) wherein the radicals have the meanings indicated, and their physiologically acceptable salts and processes for their preparation described. The compounds are suitable for. As for the treatment and / or prevention of disorders of the fatty acid metabolism and glucose utilization disorders and disorders in which insulin resistance plays a role. |
| priorityDate |
2004-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |